Biohaven Strikes Epilepsy License With $400 Million Near-Term Cash Package Biohaven agreed to license its Kv7 epilepsy platform to SK Biopharmaceuticals in...
https://www.narrowit.com/news/biohaven-sk-opakalim-kv7-license-cash-milestones-2026-08-26
#Biohaven #BHVN #SkBiopharmaceuticals #Opakalim
https://www.narrowit.com/news/biohaven-sk-opakalim-kv7-license-cash-milestones-2026-08-26
#Biohaven #BHVN #SkBiopharmaceuticals #Opakalim
Biohaven and SK Sign Global Opakalim Kv7 License | Narrowit.com
Biohaven agreed to license opakalim and its Kv7 platform to SK Biopharmaceuticals for near-term cash, milestones, royalties and assumed obligations.
www.narrowit.com
August 26, 2026 at 10:22 AM
Biohaven Strikes Epilepsy License With $400 Million Near-Term Cash Package Biohaven agreed to license its Kv7 epilepsy platform to SK Biopharmaceuticals in...
https://www.narrowit.com/news/biohaven-sk-opakalim-kv7-license-cash-milestones-2026-08-26
#Biohaven #BHVN #SkBiopharmaceuticals #Opakalim
https://www.narrowit.com/news/biohaven-sk-opakalim-kv7-license-cash-milestones-2026-08-26
#Biohaven #BHVN #SkBiopharmaceuticals #Opakalim
In the first piece of news from the #BIOInternationalConvention, #InsilicoMedicine has teamed up with #SKBiopharmaceuticals on a wide-ranging #partnership to use #AI to find #neuroimmune drug candidates for #centralnervoussystem diseases.
pharmaphorum.com/news/insilic...
pharmaphorum.com/news/insilic...
Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance
Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.
pharmaphorum.com
June 22, 2026 at 11:09 AM
In the first piece of news from the #BIOInternationalConvention, #InsilicoMedicine has teamed up with #SKBiopharmaceuticals on a wide-ranging #partnership to use #AI to find #neuroimmune drug candidates for #centralnervoussystem diseases.
pharmaphorum.com/news/insilic...
pharmaphorum.com/news/insilic...